{"transactions":[{"id":1925893,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-04-05T22:30:06.000Z","date":"2023-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6141,"price":16.75,"value":102861.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 268,554 previously reported unvested restricted stock units."}],"balance_after":346827,"source":{"system":"sec-edgar","filing":"0001209191-23-023445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123023445/doc4.xml","form_type":"4"}},{"id":2034131,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-04T02:42:05.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":5142,"price":21.54,"value":110758.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 287,130 shares of unvested restricted stock units."}],"balance_after":352968,"source":{"system":"sec-edgar","filing":"0001209191-23-007203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123007203/doc4.xml","form_type":"4"}},{"id":2059358,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:10:02.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 307,621 unvested restricted stock units."}],"balance_after":358110,"source":{"system":"sec-edgar","filing":"0001209191-23-002662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002662/doc4.xml","form_type":"4"}},{"id":2059357,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:10:02.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":40764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024."}],"balance_after":276143,"source":{"system":"sec-edgar","filing":"0001209191-23-002662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002662/doc4.xml","form_type":"4"}},{"id":2059356,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:10:02.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023."}],"balance_after":235379,"source":{"system":"sec-edgar","filing":"0001209191-23-002662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002662/doc4.xml","form_type":"4"}},{"id":2059366,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:08:13.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 307,621 unvested restricted stock units."}],"balance_after":358110,"source":{"system":"sec-edgar","filing":"0001209191-23-002660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002660/doc4.xml","form_type":"4"}},{"id":2059365,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:08:13.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":40764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024."}],"balance_after":276143,"source":{"system":"sec-edgar","filing":"0001209191-23-002660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002660/doc4.xml","form_type":"4"}},{"id":2059364,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-10T00:08:13.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a \"corporate transaction\" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023."}],"balance_after":235379,"source":{"system":"sec-edgar","filing":"0001209191-23-002660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002660/doc4.xml","form_type":"4"}},{"id":2126419,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-11-03T20:34:11.000Z","date":"2022-11-01","kind":"tax_withholding","acquired":false,"shares":2369,"price":16.21,"value":38401.49,"ownership":{"direct":true},"balance_after":186551,"source":{"system":"sec-edgar","filing":"0001209191-22-055521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122055521/doc4.xml","form_type":"4"}},{"id":2191403,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-09T22:00:34.000Z","date":"2022-08-05","kind":"tax_withholding","acquired":false,"shares":1450,"price":22.77,"value":33016.5,"ownership":{"direct":true},"balance_after":188920,"source":{"system":"sec-edgar","filing":"0001209191-22-045058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122045058/doc4.xml","form_type":"4"}},{"id":2305962,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-05T23:49:23.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":2041,"price":33.04,"value":67434.64,"ownership":{"direct":true},"balance_after":188839,"source":{"system":"sec-edgar","filing":"0001209191-22-023339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122023339/doc4.xml","form_type":"4"}},{"id":2305961,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-05T23:49:23.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":3899,"price":33.04,"value":128822.96,"ownership":{"direct":true},"balance_after":190880,"source":{"system":"sec-edgar","filing":"0001209191-22-023339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122023339/doc4.xml","form_type":"4"}},{"id":2415009,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Share Units","published_at":"2022-02-03T21:48:17.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance-based vesting restricted stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the \"Product Revenue Vesting Percentage\"), as modified by a total shareholder return (\"TSR\") modifier (the \"TSR Modifier\"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance-based vesting restricted stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the \"Product Revenue Vesting Percentage\"), as modified by a total shareholder return (\"TSR\") modifier (the \"TSR Modifier\"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group."}],"balance_after":81967,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-22-006835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122006835/doc4.xml","form_type":"4"}},{"id":2415008,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-03T21:48:17.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, February 1, 2022."}],"balance_after":194779,"source":{"system":"sec-edgar","filing":"0001209191-22-006835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122006835/doc4.xml","form_type":"4"}},{"id":2505511,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-18T22:39:19.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":1670,"price":31.14,"value":52003.8,"ownership":{"direct":true},"balance_after":112812,"source":{"system":"sec-edgar","filing":"0001209191-21-065552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121065552/doc4.xml","form_type":"4"}},{"id":2531198,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-02T01:18:13.000Z","date":"2021-11-01","kind":"tax_withholding","acquired":false,"shares":2369,"price":36.87,"value":87345.03,"ownership":{"direct":true},"balance_after":109903,"source":{"system":"sec-edgar","filing":"0001209191-21-062275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121062275/doc4.xml","form_type":"4"}},{"id":2610812,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-08-09T12:29:54.000Z","date":"2021-08-05","kind":"tax_withholding","acquired":false,"shares":1450,"price":37.98,"value":55071.0,"ownership":{"direct":true},"balance_after":112272,"source":{"system":"sec-edgar","filing":"0001209191-21-050298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121050298/doc4.xml","form_type":"4"}},{"id":2759279,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Share Units","published_at":"2021-04-05T22:27:47.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":40764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES)\nas of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES)\nas of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."}],"balance_after":40764,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":40764},"source":{"system":"sec-edgar","filing":"0001209191-21-025402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121025402/doc4.xml","form_type":"4"}},{"id":2759278,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-05T22:27:47.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":2784,"price":42.93,"value":119517.12,"ownership":{"direct":true},"balance_after":113722,"source":{"system":"sec-edgar","filing":"0001209191-21-025402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121025402/doc4.xml","form_type":"4"}},{"id":2759277,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-05T22:27:47.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":40764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2021."}],"balance_after":116506,"source":{"system":"sec-edgar","filing":"0001209191-21-025402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121025402/doc4.xml","form_type":"4"}},{"id":2996863,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-02T23:28:10.000Z","date":"2020-11-01","kind":"tax_withholding","acquired":false,"shares":1466,"price":31.26,"value":45827.16,"ownership":{"direct":true},"balance_after":74181,"source":{"system":"sec-edgar","filing":"0001209191-20-056465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120056465/doc4.xml","form_type":"4"}},{"id":3062470,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-08-11T21:56:15.000Z","date":"2020-08-07","kind":"tax_withholding","acquired":false,"shares":897,"price":33.24,"value":29816.28,"ownership":{"direct":true},"balance_after":75647,"source":{"system":"sec-edgar","filing":"0001209191-20-046214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120046214/doc4.xml","form_type":"4"}},{"id":3115339,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Share Units","published_at":"2020-06-10T21:41:30.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents market-based vesting performance stock units (\"PSUs\") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return (\"TSR\") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile."}],"balance_after":45872,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":45872},"source":{"system":"sec-edgar","filing":"0001209191-20-035636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120035636/doc4.xml","form_type":"4"}},{"id":3184673,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T21:18:34.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":107372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2020."}],"balance_after":107372,"derivative":{"exercise_price":26.09,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":107372},"source":{"system":"sec-edgar","filing":"0001209191-20-023302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120023302/doc4.xml","form_type":"4"}},{"id":3184672,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-04-03T21:18:34.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":33538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant\ndate, April 1, 2020."}],"balance_after":75266,"source":{"system":"sec-edgar","filing":"0001209191-20-023302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120023302/doc4.xml","form_type":"4"}},{"id":3239577,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-02T12:10:37.000Z","date":"2020-02-27","kind":"purchase","acquired":true,"shares":2900,"price":35.4812,"value":102895.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.23 to $35.50, inclusive. The reporting person undertakes to provide Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":41728,"source":{"system":"sec-edgar","filing":"0001209191-20-014262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120014262/doc4.xml","form_type":"4"}},{"id":3380958,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-05T22:04:08.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":81449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, November 1, 2019."}],"balance_after":81449,"derivative":{"exercise_price":41.52,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":81449},"source":{"system":"sec-edgar","filing":"0001209191-19-055270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119055270/doc4.xml","form_type":"4"}},{"id":3380957,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-05T22:04:08.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":24085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, November 1, 2019."}],"balance_after":38828,"source":{"system":"sec-edgar","filing":"0001209191-19-055270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119055270/doc4.xml","form_type":"4"}},{"id":3447819,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of Global Spine"}}],"security":"Stock Option (right to boy)","published_at":"2019-08-05T23:14:55.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":50711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, August 5, 2019."}],"balance_after":50711,"derivative":{"exercise_price":50.87,"expiration_date":"2029-08-05","underlying":"Common Stock","underlying_shares":50711},"source":{"system":"sec-edgar","filing":"0001209191-19-044717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119044717/doc4.xml","form_type":"4"}},{"id":3447818,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":114673,"kind":"person","name":"Serbousek Jon Carl","position":1,"cik":"0001536875","reported_name":"Serbousek Jon Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of Global Spine"}}],"security":"Common Stock","published_at":"2019-08-05T23:14:55.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":14743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, August 5, 2019."}],"balance_after":14743,"source":{"system":"sec-edgar","filing":"0001209191-19-044717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119044717/doc4.xml","form_type":"4"}}]}